CN Patent

CN105142612A — 用于直肠给药的药物组合物

Assigned to Cipla Ltd · Expires 2015-12-09 · 10y expired

What this patent protects

本发明涉及包含非达霉素的用于直肠给药的药物组合物，涉及制备该用于直肠给药的药物组合物的方法。本发明还涉及包含用于直肠给药的可发泡药物组合物的气雾剂罐，所述可发泡药物组合物包含非达霉素，并还涉及治疗或保持减轻感染，如艰难梭菌引起的腹泻。

USPTO Abstract

本发明涉及包含非达霉素的用于直肠给药的药物组合物，涉及制备该用于直肠给药的药物组合物的方法。本发明还涉及包含用于直肠给药的可发泡药物组合物的气雾剂罐，所述可发泡药物组合物包含非达霉素，并还涉及治疗或保持减轻感染，如艰难梭菌引起的腹泻。

Drugs covered by this patent

Patent Metadata

Patent number
CN105142612A
Jurisdiction
CN
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Cipla Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.